000 | 01352 a2200301 4500 | ||
---|---|---|---|
005 | 20250516100632.0 | ||
264 | 0 | _c20130304 | |
008 | 201303s 0 0 eng d | ||
022 | _a1538-7755 | ||
024 | 7 |
_a10.1158/1055-9965.EPI-12-0724 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWilliamson, Daniel | |
245 | 0 | 0 |
_aInconvenience of convenience cohorts--letter. _h[electronic resource] |
260 |
_bCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _cAug 2012 |
||
300 |
_a1388 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
650 | 0 | 4 |
_aClinical Trials as Topic _xstandards |
650 | 0 | 4 |
_aForkhead Transcription Factors _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPAX7 Transcription Factor _xgenetics |
650 | 0 | 4 |
_aRhabdomyosarcoma _xdiagnosis |
700 | 1 | _aMissiaglia, Edoardo | |
700 | 1 | _aChisholm, Julia | |
700 | 1 | _aShipley, Janet | |
773 | 0 |
_tCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _gvol. 21 _gno. 8 _gp. 1388 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1055-9965.EPI-12-0724 _zAvailable from publisher's website |
999 |
_c21897746 _d21897746 |